Avantor (NYSE:AVTR) Posts Quarterly Earnings Results, Beats Expectations By $0.01 EPS

Avantor (NYSE:AVTR - Get Free Report) released its quarterly earnings results on Wednesday. The company reported $0.27 earnings per share for the quarter, beating the consensus estimate of $0.26 by $0.01, RTT News reports. Avantor had a return on equity of 12.24% and a net margin of 4.54%. During the same quarter in the previous year, the business posted $0.22 EPS.

Avantor Trading Down 3.1 %

AVTR traded down $0.60 on Tuesday, hitting $18.42. The company had a trading volume of 6,740,329 shares, compared to its average volume of 5,460,743. The company has a market cap of $12.53 billion, a PE ratio of 40.03, a PEG ratio of 3.87 and a beta of 1.28. Avantor has a 12-month low of $18.19 and a 12-month high of $28.00. The company has a quick ratio of 1.06, a current ratio of 1.54 and a debt-to-equity ratio of 0.84. The business's fifty day simple moving average is $21.68 and its 200 day simple moving average is $23.44.

Analysts Set New Price Targets

A number of equities analysts recently commented on the company. Raymond James reaffirmed an "outperform" rating and issued a $24.00 target price (down from $26.00) on shares of Avantor in a report on Monday. Stifel Nicolaus decreased their price target on Avantor from $28.00 to $26.00 and set a "buy" rating on the stock in a report on Monday. Barclays decreased their price target on Avantor from $26.00 to $23.00 and set an "overweight" rating on the stock in a report on Monday. Royal Bank of Canada decreased their price target on Avantor from $33.00 to $31.00 and set an "outperform" rating on the stock in a report on Monday. Finally, Wells Fargo & Company decreased their price target on Avantor from $28.00 to $25.00 and set an "overweight" rating on the stock in a report on Monday. Three investment analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $26.15.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.